DK0651609T3 - Pasteurella multocida toxoidvacciner - Google Patents

Pasteurella multocida toxoidvacciner

Info

Publication number: DK0651609T3
Authority: DK; Denmark
Prior art keywords: pasteurella multocida; multocida; methods; toxoid vaccines; vaccines
Prior art date: 1990-06-13

Application number

DK91913518T

Other languages

English (en)

Inventor

Joseph C Frantz

David S Roberts

Leroy A Swearingin

Richard J Kemmy

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-06-13

Filing date

1991-06-10

Publication date

1999-12-06

1991-06-10 Application filed by Pfizer filed Critical Pfizer

1999-12-06 Application granted granted Critical

1999-12-06 Publication of DK0651609T3 publication Critical patent/DK0651609T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Mycology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

DK91913518T 1990-06-13 1991-06-10 Pasteurella multocida toxoidvacciner DK0651609T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US53745490A	1990-06-13	1990-06-13
PCT/US1991/004092 WO1991019419A1 (en)	1990-06-13	1991-06-10	Pasteurella multocida toxoid vaccines

Publications (1)

Publication Number	Publication Date
DK0651609T3 true DK0651609T3 (da)	1999-12-06

Family

ID=24142703

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91913518T DK0651609T3 (da)	1990-06-13	1991-06-10	Pasteurella multocida toxoidvacciner

Country Status (10)

Country	Link
US (1)	US5536496A (da)
EP (1)	EP0651609B1 (da)
JP (1)	JP3178720B2 (da)
AT (1)	ATE183202T1 (da)
AU (2)	AU8195391A (da)
DE (1)	DE69131525T2 (da)
DK (1)	DK0651609T3 (da)
ES (1)	ES2136064T3 (da)
GR (1)	GR3031487T3 (da)
WO (1)	WO1991019419A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0669971B1 (en) *	1991-11-15	2003-03-19	Pfizer Inc.	Method of producing gram-negative bacterial vaccines
AU669681B2 (en) *	1991-11-15	1996-06-20	Pfizer Inc.	Pasteurella multocida toxoid vaccines
USRE39494E1 (en) *	1992-02-27	2007-02-27	Intervet Inc.	Inactivated mycoplasma hyopneumoniae and uses therefor
EP0773030B8 (en) *	1994-06-10	2004-01-14	Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute	Process for purifying dermonecrotic toxin produced by bordetella bronchiseptica
US7626017B2 (en) *	1997-10-31	2009-12-01	Pressure Biosciences, Inc.	Pressure-enhanced extraction and purification
AU4078699A (en) *	1998-05-15	1999-12-06	Mkb Investments Limited Partnership	Compositions and method for immunizing poultry
AU769539B2 (en) *	1999-01-29	2004-01-29	Zoetis Services Llc	Adjuvants for use in vaccines
US6517844B1 (en) *	1999-05-14	2003-02-11	Marshall K. Brinton	Compositions and method for immunizing polutry
MY128159A (en) *	2000-06-30	2007-01-31	Wyeth Corp	Methods and composition for oral vaccination
US10286048B2 (en) *	2017-07-28	2019-05-14	James G. McCabe	Polyvalent venom vaccines
US11446367B2 (en) *	2017-07-28	2022-09-20	Zootoxins, Llc	Immunization with polyvalent venom vaccines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4789544A (en) *	1986-05-23	1988-12-06	Midcon Labs. Inc.	Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
DK199588D0 (da) *	1988-04-12	1988-04-12	Nordisk Droge & Kemikalie	Vaccine

1991
- 1991-06-10 ES ES91913518T patent/ES2136064T3/es not_active Expired - Lifetime
- 1991-06-10 DE DE69131525T patent/DE69131525T2/de not_active Expired - Lifetime
- 1991-06-10 DK DK91913518T patent/DK0651609T3/da active
- 1991-06-10 AU AU81953/91A patent/AU8195391A/en not_active Abandoned
- 1991-06-10 JP JP51228291A patent/JP3178720B2/ja not_active Expired - Lifetime
- 1991-06-10 EP EP91913518A patent/EP0651609B1/en not_active Expired - Lifetime
- 1991-06-10 WO PCT/US1991/004092 patent/WO1991019419A1/en active IP Right Grant
- 1991-06-10 AT AT91913518T patent/ATE183202T1/de not_active IP Right Cessation
1995
- 1995-03-03 AU AU13628/95A patent/AU685569B2/en not_active Expired
- 1995-05-12 US US08/439,714 patent/US5536496A/en not_active Expired - Lifetime
1999
- 1999-10-08 GR GR990402580T patent/GR3031487T3/el unknown

Also Published As

Publication number	Publication date
DE69131525T2 (de)	1999-11-25
DE69131525D1 (de)	1999-09-16
WO1991019419A1 (en)	1991-12-26
US5536496A (en)	1996-07-16
AU8195391A (en)	1992-01-07
AU685569B2 (en)	1998-01-22
ATE183202T1 (de)	1999-08-15
ES2136064T3 (es)	1999-11-16
EP0651609B1 (en)	1999-08-11
JPH05508407A (ja)	1993-11-25
EP0651609A4 (en)	1993-06-30
GR3031487T3 (en)	2000-01-31
JP3178720B2 (ja)	2001-06-25
EP0651609A1 (en)	1995-05-10
AU1362895A (en)	1995-08-10

Similar Documents

Publication	Publication Date	Title
DE69728380D1 (de)	2004-05-06	Streptokokken c5a peptidase impfstoff
ATE199644T1 (de)	2001-03-15	Ein hydrophobisches sulfolipidisches polysaccharid enthaltendes adjuvans für impfstoffe
CA2089552A1 (en)	1992-02-17	Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof
NO930938L (no)	1993-03-16	Forbedrede vaksiner
CY1106983T1 (el)	2012-09-26	ΕΜΒΟΛΙΟ ΠΕΠΤΙΔΑΣΗΣ C5a ΣΤΡΕΠΤΟΚΟΚΚΟΥ
DK0651609T3 (da)	1999-12-06	Pasteurella multocida toxoidvacciner
ATE217196T1 (de)	2002-05-15	Impfstoff auf urease-basis gegen helicobacter infektionen
NO932102D0 (no)	1993-06-09	Oligosakkarid avledet fra antigent polysakkarid erholdt fra et patogen
LU91594I2 (fr)	2009-10-12	Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de virus poliomyélitique inactivé type 1, type 2 et type 3 (Infanrix - IPV)
DK22389A (da)	1989-07-21	Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma
DE69113991D1 (de)	1995-11-23	Impfstoff.
EP0529019A4 (en)	1993-07-28	Nematode vaccine
CA2312296A1 (en)	1991-12-14	Pasteurella multocida toxoid vaccines
CA2086258A1 (en)	1991-12-14	Pasteurella multocida toxoid vaccines
NO913131L (no)	1992-02-14	Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
DE69331459D1 (de)	2002-02-21	Parenterale immunisierung gegen rotavirus
NL7810753A (nl)	1979-05-02	Gecombineerd vaccin voor immunisering tegen infecties door haemophilus influenza, type b.
IT8722791A0 (it)	1987-11-27	Attenuato cosi' ottenuto. procedimento per la preparazione di un ceppo mutante migliorato di bordetella bronchiseptica utile per un vaccino attenuato vivo per la protezione da infezioni di b.bronchiseptica e vaccino ar vivo
EP0563288A4 (en)	1994-08-24	Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
RU93005000A (ru)	1996-10-27	Композиция вакцин, способ ее получения, способ исключения иммунной реакции
MX9604262A (es)	1997-12-31	Antigenos de pasteurellaceae y vacunas relacionadas.